Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs

New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds

Ion Chromatography Analysis

To support a wider range of ion chromatography analysis with one instrument, Thermo Fisher Scientific Inc., today launched the Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes. The new analytical instrument is designed to be easily reconfigurable, providing those who require determination of ionic and small polar compounds with a one stop shop for consistent, reliable ion analysis.

Food and Water Supply Safety

As safety concerns increase around our environment, particularly our food and water supply, scientists will require versatile and sensitive instruments for adequate testing and analysis. Aligned with Thermo Fisher’s mission to enable our customers to make the world healthier, cleaner and safer, the Dionex Inuvion IC system equips environmental, industrial, municipal water, and food and beverage labs with the necessary equipment to determine ionic contaminants in water. The technology also helps identify corrosive contaminants in oil and gas, as well as provide quality assurance and quality control of small ionic compounds in food, beverage, and pharmaceuticals.

Dionex Inuvion System

The Dionex Inuvion system helps meet labs’ needs to operate more efficiently with easily configurable workflows and a small footprint. The flexible platform can be tailored to meet current analytical requirements and helps extend IC capabilities to adapt to changing sample types and workflow requirements in the future more easily and cost-effectively.

Lidija Raicevic, VP and General Manager of Ion Chromatography and Sample Preparation at Thermo Fisher Scientific

“As the originator of ion chromatography, we continue to lead innovation in all areas of instrumentation and column chemistry to meet our customers’ growing needs for better resolution, faster results, and intuitive lab experience. The Dionex Inuvion system is built on years of expertise and this new system will provide enhanced capabilities to labs of all sizes while helping streamline our IC portfolio so labs can more easily find the technology that is best for their needs.”

The Dionex Inuvion IC system features new advanced pump technology that improves speed, quality, and reproducibility; operator-friendly engineering to enhance the operator experience; and user-installable accessories that extend its capabilities and ultimately help achieve the highest quality results.

For more information about the Dionex Inuvion IC system, including technical specifications and applications, please visit www.thermofisher.com/inuvion.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”